In conclusion, GH and IGF-1 may offer a promising avenue for the management of obesity, but caution should be exercised, and more research is needed to fully understand their effects, develop safe and effective treatment strategies, and validate their findings in human populations. The gene discussed is GH1; the disease is obesity due to melanocortin 4 receptor deficiency.